USIran Standoff Deepens as Trump Rejects Peace Counteroffer Threatening Global Energy Supplies Suzlon Q4FY26 Profit Dip 575 as Revenue Jumps 45 on Record Wind Turbine Deliveries Tokenization Could Reshape Banking Landscape Strategys Michael Saylor Suggests Oil Price Reversal Highlights Persistent Geopolitical Risk Premium in Crude Markets Chinas Commerce Minister Skips APEC Opening Amid Urgent Official Business Trade Representative Chairs Meeting Move Over Tesla Another RoboTaxi Stock Accelerates Its Autonomous Ambitions Edgewell Personal Care EPC Q1 2026 Earnings EPS Misses Estimates but Shares Gain ASTC Q1 2024 Earnings Reported Loss of 179 Per Share Amidst Market Challenges ARL Q3 2024 Earnings Loss Per Share Widens Amidst Challenging Real Estate Market LASR Q1 2026 Earnings EPS Surges Past Estimates Stock Gains Amid Strategic Shifts Virtu Financial Q1 2026 Earnings EPS Surges Past Estimates Stock Edges Higher Fulcrum Therapeutics Q1 2026 Earnings Narrowing Losses as Pipeline Advances Strata Critical Medical SRTA Holds Steady Near Key Resistance Level PGIM High Yield Bond Fund ISD Holds Steady at 1299 as Income Investors Seek Stability PLBY Retreats to 128 Bearish Momentum Tests Critical Support Sentage Holdings Inc SNTG Edges Higher Amid Consolidation Near Key Resistance Ford Motor Company F Pushes Higher After Positive Session Market Expectations Shift Toward Fed Rate Hike After Hot Inflation Data STKS Q1 2026 Earnings EPS Misses Estimates by Wide Margin Amid Operational Headwinds Charter Communications CHTR Holds Near Support as Modest Decline Continues Perella Weinberg Partners Q1 2026 Earnings EPS Misses Estimates as Advisory Revenue Remains Undisclosed GECCI Q1 2026 Earnings Strong EPS Beat Driven by Improved Investment Income NWFL Q1 2026 Earnings Strong EPS Beat Amid Challenging Environment TD Q1 2026 Earnings EPS Beat Bolsters Investor Confidence Amidst Ongoing Regulatory Challenges GNPX Q1 2026 Earnings ClinicalStage Biotech Reports Net Loss with No Revenue Stock Moves Up 074 TLN Q1 2026 Earnings EPS Falls Far Short of Estimates Yet Shares Edge Higher Serina Therapeutics Inc SER Q1 2026 Earnings EPS Miss Amid Continued Development Progress